Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study [0.03%]
日本哮喘患者每日一次的单吸入器氟替卡松福莫特鲁/乌美溴铵维兰特罗与氟替卡松福莫特鲁/维兰特罗疗效和安全性：CAPTAIN研究
Yoichi Nakamura,Soichiro Hozawa,Hironori Sagara et al.
Yoichi Nakamura et al.
Objective: In CAPTAIN, a double-blind, parallel-group, Phase IIIA study, fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) improved lung function, symptoms and asthma control versus FF/VI in patients with inadequat...
Randomized Controlled Trial
Current medical research and opinion. 2021 Sep;37(9):1657-1665. DOI:10.1080/03007995.2021.1944849 2021
Educational needs, perception, and perspectives of oncologists regarding compassionate use programs in Asia [0.03%]
亚洲肿瘤学界对同情用药项目的需求、认知和观点
Manmohan Singh,Ankita Jain,Wade Fang et al.
Manmohan Singh et al.
Objective: This study was conducted to capture the educational needs, perceptions, and perspectives of oncologists towards Compassionate Use Programs (CUPs) in Asia, with the aim of gathering insights related to unmet nee...
Empirical anti-tuberculous therapy for the massive pericardial effusion of unknown etiology [0.03%]
不明原因大量心包积液的实验性抗结核治疗
Chenyu Wang,Ligang Fang,Wenling Zhu et al.
Chenyu Wang et al.
Objective: The aim of this study was to evaluate the efficacy and safety of empirical anti-tuberculous therapy (ATT) in patients with massive pericardial effusion (MPE) of unknown etiology in China. ...
Impact of treatment-related discussions on healthcare resource use and costs among patients with severe mental illness [0.03%]
与严重精神疾病患者治疗相关讨论对医疗资源使用和成本的影响
Felicia Forma,Eleena Koep,John White et al.
Felicia Forma et al.
Objective: Serious mental illnesses (SMIs), including schizophrenia, bipolar disorder, and major depressive disorder (MDD), are often treated with antipsychotic medications. Unfortunately, medication non-adherence is wide...
Novel oxytocin receptor antagonists for tocolysis: a systematic review and meta-analysis of the available data on the efficacy, safety, and tolerability of retosiban [0.03%]
用于抑制早产的新型催产素受体拮抗剂：系统评价和荟萃分析及总结瑞他西班的有效性、安全性和耐受性数据
Greg Marchand,Richard Blumrick,Alexandra D Ruuska et al.
Greg Marchand et al.
Objective: To assess the efficacy, safety, and tolerability of retosiban-a novel tocolytic unavailable in the US-in the management of preterm labor. Metho...
Changes in prostate cancer screening practice by blood PSA testing between 2011 and 2017, a French population-based study [0.03%]
法国基于人群的前列腺癌筛查行为变化(2011年-2017年)调查研究——通过血液PSA检测
Lucie-Marie Scailteux,Valérian Capelle,Frédéric Balusson et al.
Lucie-Marie Scailteux et al.
Objective: The aim of the study was to determine the trend of first blood prostate-specific antigen (PSA) test prescription in France between 2011 and 2017, based on the assumption that prostate cancer (PCa) screening is ...
Monitoring established Crohn's disease with pan-intestinal video capsule endoscopy in Europe: clinician consultation using the nominal group technique [0.03%]
欧洲运用整肠视频胶囊内镜监测克罗恩病的建立与应用：名义群体技术临床会诊
Cristina Carretero,Franck Carbonnel,Marc Ferrante et al.
Cristina Carretero et al.
Objective: Monitoring established Crohn's disease (CD) through a "treat-to-target" strategy aims to reduce and prevent long-term bowel damage and disability. Despite the availability of different monitoring techniques, th...
Budget impact analysis of high-flow nasal cannula for infant bronchiolitis: the Colombian National Health System perspective [0.03%]
哥伦比亚国家卫生系统视角下的婴儿支气管炎高流量鼻导管预算影响分析
Jefferson Antonio Buendía,Ranniery Acuña-Cordero,Carlos E Rodriguez-Martinez
Jefferson Antonio Buendía
Background: High-flow nasal cannula is a non-invasive ventilation system that was introduced as an alternative to continuous positive airway pressure), with a marked increase in its use in pediatric care settings. However...
Martin Krbec,Kateřina Koudelková,František Duška
Martin Krbec
Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experiment [0.03%]
英国复发缓解型多发性硬化症治疗患者的神经学家偏好：基于离散选择实验的成果
Tom Tencer,Oliver Will,Jinender Kumar et al.
Tom Tencer et al.
Objective: To evaluate and compare patient and neurologist preferences for relapsing-remitting multiple sclerosis (RRMS) treatments with respect to benefits and risks associated with common and novel disease-modifying the...